Jess F. Gamble
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Genetics top 5%
- Pulmonary and Respiratory Medicine top 10%
- Neurology top 5%
- Co-authors
- Lillian M. FullerC. C. ShullenbergerHenry E. WilsonCharles A. ColtmanEugene M. McKelveyJames J. ButlerRobert W. TalleyMontague Lane
- Topics
- Lymphoma Diagnosis and Treatment (18 papers)Chronic Lymphocytic Leukemia Research (6 papers)CNS Lymphoma Diagnosis and Treatment (6 papers)
- Partner nations
- United States
In The Last Decade
Jess F. Gamble
21 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Pathology and Forensic Medicine 1.0k
- Oncology 587
- Genetics 340
- Pulmonary and Respiratory Medicine 316
- Neurology 315
Countries citing papers authored by Jess F. Gamble
This map shows the geographic impact of Jess F. Gamble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jess F. Gamble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jess F. Gamble more than expected).
Fields of papers citing papers by Jess F. Gamble
This network shows the impact of papers produced by Jess F. Gamble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jess F. Gamble. The network helps show where Jess F. Gamble may publish in the future.
Co-authorship network of co-authors of Jess F. Gamble
This figure shows the co-authorship network connecting the top 25 collaborators of Jess F. Gamble. A scholar is included among the top collaborators of Jess F. Gamble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jess F. Gamble. Jess F. Gamble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 58 | |
| 3 | 24 | |
| 4 | 36 | |
| 5 | 30 | |
| 6 | Team approach to management of non-Hodgkin's lymphomas: past and present. | 7 |
| 7 | 41 | |
| 8 | Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomabreakdown → | 625 |
| 9 | 47 | |
| 10 | 20 | |
| 11 | 16 | |
| 12 | 27 | |
| 13 | 8 | |
| 14 | 55 | |
| 15 | 66 | |
| 16 | 9 | |
| 17 | 12 | |
| 18 | 40 | |
| 19 | 162 | |
| 20 | 6 |
About Jess F. Gamble
Jess F. Gamble is a scholar working on Microbiology, Pathology and Forensic Medicine and Genetics, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.0k citations), Genetics (340 citations) and Oncology (587 citations). Jess F. Gamble has collaborated with scholars based in United States. Frequent co-authors include Lillian M. Fuller, C. C. Shullenberger, Henry E. Wilson, Charles A. Coltman, Eugene M. McKelvey, James J. Butler, Robert W. Talley, Montague Lane, P Grozea and Jeffrey A. Gottlieb. Their work appears in journals such as Annals of Internal Medicine, Cancer and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.